Penn Sues St. Jude Hospital Over Cancer Treatment Patent

The University of Pennsylvania sued St. Jude Children’s Research Hospital over a patent for creating genetically modified versions of immune cells to treat cancer.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.